Redeye strengthens its positive view of Formpipe following the Q3 report, showing a rebound in ACV a...
* Faces similar issues to Betco, indicating market-wide issues * '26e-'27e EBITDA down 3% * Trading ...
Byggmästaren är ett långsiktigt investmentbolag med fokus på beprövade, uthålliga och skalbara affär...
* Strong NOI margin behind rec. PTP +1% vs ABGSCe * Cons to raise estimates (rec.
Redeye provides a short comment on the technology evaluation agreement with SeeQ Diagnostics.
Redeye updates its estimates following Enviro’s Q3 report.
Fiskars lowered its guidance this evening. The company now expects its 2025 comparable EBIT to be EU...
* Q3 was a step back, but 2026e should recover * We cut adj.
Today, Binero announced its acquisition of Hibox amounting to SEK75m, at multiples of 11x EBIT and 6...
Redeye comments on Enviro’s Q3 report, which presented no real operational surprises.
* Lasernet +13% organic growth y-o-y, +2% vs. ABGSCe * 13% adj.
Cell Impact verkar fortsatt i en mycket utmanande marknad där både bränslecells- och elektrolyssegme...
Redeye comments on Formpipe’s Q3, showing ARR growth and EBITDA-CAPEX in line with our expectations.
DT’s CMD outlined strategy for the next five years.
GiG Software Q3-results were in line with our expectations while the company reiterated its guidance...
Redeye comments on Mendus announcing a directed share issue.
Redeye returns with an updated view following Nekkar’s soft Q3 figures driven by Syncrolift, while F...
Redeye provides an update following Corline’s Q3 2025 report.
Redeye comments on Lytix' third quarter report 2025.
Redeye return with a research update following BioArctic's Q3 report and latest newsflow.
